These medications are administered once weekly via a subcutaneous injectionmeaning the medication is injected just under the skin, typically in the abdomen, thigh, or upper arm
The discussion around getting pregnant on tirzepatide and the guidance on GLP-1 use during breastfeeding address these important safety topics
"By addressing weight, glycemia and obesity-related complications together, these results highlight retatrutide's potential across the cardiometabolic spectrum and reinforce our commitment to delivering options that meet patients' needs and preferences." In TRANSCEND-T2D-1, retatrutide met the primary and all key secondary endpoints at 40 weeks in adults with type 2 diabetes, delivering significant A1C reduction along with substantial weight loss
But if you stay off the drug, expect cravings to return with full force
Therefore, a distinction between these subtypes of DM is important for therapeutic decision making